AprilBio Co.,Ltd. Logo

AprilBio Co.,Ltd.

Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.

397030 | KO

Overview

Corporate Details

ISIN(s):
KR7397030008
LEI:
Country:
South Korea
Address:
강원도 춘천시 강원대학길 1 의생명과학대학 B동 602호, 춘천시

Description

AprilBio is a biotechnology company that develops innovative biologic drugs, including therapeutic antibodies and recombinant proteins. The company's core is its proprietary SAFA (anti-Serum Albumin Fab-Associated) platform technology, which utilizes an albumin-binding antibody fragment to create long-acting therapeutics. This platform is designed to enhance the efficacy, safety, and plasma half-life of drug candidates while minimizing adverse effects. AprilBio's research and development pipeline focuses on addressing unmet medical needs in therapeutic areas such as autoimmune diseases, oncology, and other inflammatory and rare diseases. The company advances new drug candidates through early clinical development stages for potential technology transfer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-28 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.8 KB
2025-03-18 00:00
투자판단관련주요경영사항 (자가염증질환 치료제 APBR3 관련 마일스톤 기술료 수령)
Korean 6.7 KB
2025-03-13 00:00
주주총회소집공고
Korean 126.4 KB
2025-03-13 00:00
감사보고서제출
Korean 18.2 KB
2025-03-13 00:00
사업보고서 (2024.12)
Korean 1.3 MB
2025-03-06 00:00
주주총회소집결의
Korean 15.9 KB
2025-03-06 00:00
주주총회집중일개최사유신고
Korean 5.2 KB
2025-02-14 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-02-14 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-02-13 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.5 KB
2025-02-06 00:00
기업설명회(IR)개최
Korean 6.7 KB
2024-12-17 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-12-10 00:00
주식등의대량보유상황보고서(약식)
Korean 64.0 KB
2024-12-04 00:00
주식등의대량보유상황보고서(약식)
Korean 70.2 KB
2024-11-27 00:00
주식등의대량보유상황보고서(약식)
Korean 66.0 KB

Automate Your Workflow. Get a real-time feed of all AprilBio Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AprilBio Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AprilBio Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.